Informing health system planning for biomarker-based treatment: projections of cancer prevalence to 2042 for key pan-tumour biomarkers (dMMR, MSI, high TMB) (#240)
Yoon-Jung Kang
1
,
Qingwei Luo
1
,
Jeff Cuff
1
,
John Zalcberg
2
,
Karen Canfell
1
,
Julia Steinberg
1
- Daffodil Centre, Woolloomooloo, NSW, Australia
- Department of Medical Oncology, Alfred Health , Melbourne, VIC , Australia